Celcuity (CELC) Accounts Payables (2016 - 2025)
Celcuity (CELC) reported Accounts Payables of $11.4 million for Q3 2025, up 24.67% on a YoY basis from $9.2 million in Q3 2024, and up 2.33% quarter-over-quarter from $11.2 million in Q2 2025.
Celcuity (CELC) Accounts Payables (2016 - 2025) Analysis & Trends
Celcuity has reported Accounts Payables for 10 years, with the latest figure at $11.4 million in Q3 2025.
- For the quarter ending Q3 2025, Accounts Payables rose 24.67% year-over-year to $11.4 million; the trailing twelve-month figure through Sep 2025 stood at $11.4 million (up 24.67% YoY), and the FY2024 full-year result was $9.4 million, up 84.49% from the prior year.
- Accounts Payables for Q3 2025 stood at $11.4 million, up from $11.2 million in the prior quarter.
- The five-year high for Accounts Payables was $11.4 million in Q3 2025, with the low at $318213.0 in Q1 2021.
- Historically, Accounts Payables has averaged $4.9 million across 5 years, with a median of $3.2 million in 2022.
- Annual changes were most pronounced in 2021 — Accounts Payables surged 2000.84% — and 2023, when it gained 20.13%.
- Celcuity's Accounts Payables stood at $1.5 million in 2021, then soared by 74.31% to $2.6 million in 2022, then jumped by 93.25% to $5.1 million in 2023, then surged by 84.49% to $9.4 million in 2024, then grew by 21.91% to $11.4 million in 2025.
- The last three Accounts Payables figures came in at $11.4 million (Q3 2025), $11.2 million (Q2 2025), and $9.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 34.55 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11.42 Mn |
| Jun 30, 2025 | 11.16 Mn |
| Mar 31, 2025 | 9.93 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Sep 30, 2024 | 9.16 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 5.28 Mn |
| Dec 31, 2023 | 5.08 Mn |
| Sep 30, 2023 | 5.63 Mn |
| Jun 30, 2023 | 3.02 Mn |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 647,172.00 |
| Mar 31, 2021 | 318,213.00 |
| Dec 31, 2020 | 217,377.00 |